Venn Life Sciences Holdings PLC (LON:VENN – Get Free Report) shares passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 6.85 ($0.09) and traded as high as GBX 7 ($0.09). Venn Life Sciences shares last traded at GBX 6.85 ($0.09), with a volume of 1,027,544 shares trading hands.
Venn Life Sciences Trading Up 7.0 %
The stock has a market capitalization of £4.89 million and a PE ratio of -2.14. The company has a quick ratio of 1.48, a current ratio of 2.30 and a debt-to-equity ratio of 35.83. The business’s 50-day moving average is GBX 6.85 and its two-hundred day moving average is GBX 6.85.
About Venn Life Sciences
Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling.
Featured Articles
- Five stocks we like better than Venn Life Sciences
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Rocket Lab is the Right Stock for the Right Time
- How to Use the MarketBeat Excel Dividend Calculator
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Venn Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venn Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.